Ketamine Patient-Controlled Analgesia for Acute Pain

Brief Summary

This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine are also expected to have shorter duration of supplemental oxygen requirement, fewer episodes of oxygen desaturation, improved pulmonary toilet, lower use of antiemetics, and shorter times to first bowel movement. Ketamine is further expected to be associated with decreased intensive care unit and hospital lengths of stay, faster time to maximum allowable ambulation, decreased opioid dosage at discharge, and lower report of chronic pain syndromes.

Intervention / Treatment

  • Drug: Ketamine
  • Drug: Hydromorphone

Condition or Disease

  • Acute Pain
  • Multiple Trauma
  • Fractures

Phase

Study Design

Study type: Interventional
Status: Terminated
Study results: Has Results
Age: 18 Years and older   (Adult, Older Adult)
Enrollment: 20 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Apr 14, 2020
Primary Completion: Jun 16, 2020
Completion Date: Jun 16, 2020
Study First Posted: Feb 14, 2014
Results First Posted: Sep 21, 2017
Last Updated: Sep 21, 2017

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 18

More Details

NCT Number: NCT02062879
Other IDs: Mueller2014
Study URL: https://ClinicalTrials.gov/show/NCT02062879
Last updated: Jun 17, 2022